Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) |
Healthy Volunteers, Pulmonary Arterial Hypertension | Phase1, Phase2 | Argentina Australia Belgium Brazil Czechia France Germany Greece Italy Latvia Mexico Poland Portugal Romania Serbia Spain United Kingdom United States View all |
NCT06649110 |
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE) |
Sickle Cell Disease | Phase3 | Brazil Colombia Kenya Uganda United States View all |
NCT06439082 |
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA) |
Spinal Muscular Atrophy (SMA) | Greece Ireland Israel Poland Portugal Romania Russia South Korea Taiwan United States View all |
NCT04174157 | |
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma |
Asthma | Phase3 | Argentina Brazil Bulgaria Colombia Greece Guatemala Hungary Italy Mexico Panama Portugal Romania South Africa Spain Vietnam View all |
NCT05562466 |
Home Reported Outcomes in PNH |
Paroxysmal Nocturnal Hemoglobinuria | United States | NCT06411626 | |
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis |
Diffuse Cutaneous Systemic Sclerosis | Phase2 | Argentina Austria Belgium Brazil China France Germany Greece Hungary India Italy Japan Malaysia Mexico Portugal South Korea Spain Taiwan Thailand Turkey (Türkiye) United Kingdom United States Vietnam View all |
NCT06470048 |
A 24-week rPMS Study in Real-world Setting for Enerzair |
Asthma | South Korea | NCT05274425 | |
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma |
Asthma | Phase2 | Bulgaria Colombia Guatemala Hungary Poland South Africa Spain United Kingdom View all |
NCT05222529 |
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis |
Scleroderma, Diffuse | Phase2 | Argentina Australia Austria Belgium Brazil Czechia Denmark France Germany Hungary Israel Italy Japan Netherlands Singapore South Korea Spain Switzerland Taiwan United Kingdom United States View all |
NCT06655896 |
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG. |
Generalized Myasthenia Gravis | Phase3 | Argentina Australia Brazil China Denmark France Germany Greece Israel Italy Japan Poland Portugal Serbia South Korea Spain United Kingdom United States View all |
NCT06517758 |